Human autoantibodies underlying infectious diseases

A Puel, P Bastard, J Bustamante… - Journal of Experimental …, 2022 - rupress.org
The vast interindividual clinical variability observed in any microbial infection—ranging from
silent infection to lethal disease—is increasingly being explained by human genetic and …

Molecular mechanisms that influence the macrophage M1–M2 polarization balance

N Wang, H Liang, K Zen - Frontiers in immunology, 2014 - frontiersin.org
As an essential component of innate immunity, macrophages have multiple functions in both
inhibiting or promoting cell proliferation and tissue repair. Diversity and plasticity are …

[HTML][HTML] The M1 and M2 paradigm of macrophage activation: time for reassessment

FO Martinez, S Gordon - F1000prime reports, 2014 - ncbi.nlm.nih.gov
Macrophages are endowed with a variety of receptors for lineage-determining growth
factors, T helper (Th) cell cytokines, and B cell, host, and microbial products. In tissues …

Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage

I Ushach, A Zlotnik - Journal of Leucocyte Biology, 2016 - academic.oup.com
Abstract M-CSF and GM-CSF are 2 important cytokines that regulate macrophage numbers
and function. Here, we review their known effects on cells of the macrophage-monocyte …

Pulmonary alveolar proteinosis

BC Trapnell, JA Whitsett, K Nakata - New England Journal of …, 2003 - Mass Medical Soc
In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the alveoli
because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …

Pulmonary alveolar proteinosis: progress in the first 44 years

JF Seymour, JJ Presneill - … journal of respiratory and critical care …, 2002 - atsjournals.org
Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958.
Subsequently, over 240 case reports and small series have described at least 410 cases in …

Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease

JA Whitsett, SE Wert, TE Weaver - Annual review of medicine, 2010 - annualreviews.org
The alveolar region of the lung creates an extensive epithelial surface that mediates the
transfer of oxygen and carbon dioxide required for respiration after birth. Maintenance of …

Pulmonary alveolar proteinosis

R Borie, C Danel, MP Debray, C Taille… - European …, 2011 - Eur Respiratory Soc
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease characterised by alveolar
accumulation of surfactant. It may result from mutations in surfactant proteins or granulocyte …

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor

T Kitamura, N Tanaka, J Watanabe… - The Journal of …, 1999 - rupress.org
Idiopathic pulmonary alveolar proteinosis (I-PAP) is a rare disease of unknown etiology in
which the alveoli fill with lipoproteinaceous material. We report here that I-PAP is an …

M1 and M2 immune activation in Parkinson's disease: foe and ally?

MS Moehle, AB West - Neuroscience, 2015 - Elsevier
Parkinson's Disease (PD) is a chronic and progressive neurodegenerative disorder of
unknown etiology. Autopsy findings, genetics, retrospective studies, and molecular imaging …